{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-242652","form_type":"8-K","ticker":"LXEO","cik":"0001907108","company_name":"Lexeo Therapeutics, Inc.","filed_at":"2025-10-17T23:59:59+00:00","discovered_at":"2026-05-14T18:02:41.042400+00:00","generated_at":"2026-05-17T03:26:28.050261+00:00","sec_items":["1.01","2.02","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.85,"calibrated_materiality_score":0.85,"confidence":"high","headline":"Lexeo prices $135M offering; FDA open to faster LX2006 approval path","bullets":["Priced public offering of 15.625M shares at $8.00 and $10M private placement (pre-funded warrants) to Balyasny; gross proceeds ~$135M.","Preliminary cash, cash equivalents and investments of $122.8M as of Sept 30, 2025.","FDA indicated openness to accelerated BLA for LX2006 using pooled Phase I/II and pivotal study data; enhanced manufacturing comparability required.","LX2006 interim data: sustained or deepening improvements in LVMI and frataxin in majority of 16 participants at >=6 months follow-up.","LX2020: 9 participants dosed; one Grade 3 SVT resolved; low-dose cohort shows stable cardiac parameters; more data expected Jan 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-242652","json":"https://secwatch.observer/filing/0001193125-25-242652.json","markdown":"https://secwatch.observer/filing/0001193125-25-242652.md","text":"https://secwatch.observer/filing/0001193125-25-242652.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1907108/000119312525242652/0001193125-25-242652-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1907108/000119312525242652/d52644d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T03:26:28.050261+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}